Structure–activity relationship studies of flavopiridol analogues

Structure–activity relationship studies of flavopiridol analogues Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues Thio- and Oxoflavopiridols, Cyclin-Dependent Kinase 1-Selective Inhibitors:  Synthesis and Biological Effects Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potency Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: Synthesis, SAR analysis, and biological activity Discovery of novel 5-fluoro-N²,N⁴-diphenylpyrimidine-2,4-diamines as potent inhibitors against CDK2 and CDK9 Pyrazolo[4,3-d]pyrimidines as new generation of cyclin-dependent kinase inhibitors Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy Combination of flavopiridol and embelin effectively inhibit cell growth in hepatocellular carcinoma depending on regulatory relationship between CDK6 and XIAP Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin